Cutera Regains Compliance with Nasdaq Listing Rules

Rhea-AI Summary

Cutera, Inc. (NASDAQ: CUTR) has announced that it is now in compliance with Nasdaq Listing Rule 5250(c)(1), following the filing of its Form 10-K for the period ended December 31, 2022. Previously, the company received a notification of non-compliance due to a delayed filing. The recent Form 10-K does not contain any restatements of prior financial statements and discloses no additional material weaknesses in internal controls beyond those previously reported on March 16, 2023. This compliance reaffirms Cutera’s commitment to meeting Nasdaq's requirements. The company is recognized for its innovative aesthetic and dermatology solutions, offering safe and effective treatments for practitioners worldwide since 1998.

Positive

• Cutera is now in compliance with Nasdaq Listing Rule 5250(c)(1), restoring its standing on the exchange.
• No restatements of financial statements were included in the recent Form 10-K.

Negative

• None.

BRISBANE, Calif.--(BUSINESS WIRE)-- Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, announced today that it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that based on the Company’s April 7, 2023 filing of its Form 10-K for the period ended December 31, 2022 (“Form 10-K”), Nasdaq has determined that the Company is now in compliance with the periodic filing requirement of Nasdaq Listing Rule 5250(c)(1). As previously announced, the Company received a notification letter from the Nasdaq that it was not in compliance with Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of its Form 10-K. The Company is now in compliance with all Nasdaq Listing Rules.

The Company’s Form 10-K did not include any restatements of previously issued financial statements. No additional material weaknesses in the Company’s internal control over financial reporting were disclosed in the Form 10-K beyond those previously disclosed by the Company in the amended Form 12b-25 filed by the Company on March 16, 2023.

About Cutera, Inc.

Brisbane, California-based Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that harness the power of science and nature to enable medical practitioners to offer safe and effective treatments to their patients. For more information, call +1-415-657-5500 or 1-888-4CUTERA or visit www.cutera.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230410005394/en/

Cutera, Inc.

Greg Barker

VP, Corporate FP&A

415-657-5500

IR@cutera.com

Source: Cutera, Inc.

FAQ

What does Cutera's compliance with Nasdaq Listing Rule 5250(c)(1) mean?

Cutera's compliance means it has met all periodic filing requirements set by Nasdaq, restoring its standing on the exchange.

When did Cutera file its Form 10-K?

Cutera filed its Form 10-K for the period ended December 31, 2022, on April 7, 2023.

Did Cutera report any material weaknesses in its financial reporting?

No additional material weaknesses were disclosed in Cutera's recent Form 10-K beyond those reported earlier.

What caused Cutera's previous non-compliance with Nasdaq?

Cutera's previous non-compliance was due to the delayed filing of its Form 10-K.